RVMD - Financial Reports List - Revolution Medicines, Inc. - IntrinsicAlpha

Revolution Medicines, Inc. RVMD

Healthcare - Biotechnology - NASDAQ - US

$ 36.56

-0.544 %

$ 6.8 B

Market Cap

-10.21

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-20.45%	-20.18%
Annual Report	FY	10-K	2024-12-31	0.00%	-37.52%	-41.53%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-44.13%	-42.57%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-35.54%	-43.98%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-98.28%	-87.42%
Quarterly Report	Q4	8-K	2023-12-31	-95.16%	-185.87%	-191.67%
Annual Report	FY	10-K	2023-12-31	-67.27%	-75.46%	-88.63%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-47.87%	-61.04%
Quarterly Report	Q2	8-K	2023-06-30	-58.05%	-62.87%	-75.23%
Quarterly Report	Q1	8-K	2023-03-31	-7.44%	-2.02%	-29.70%

1